Fred Hutch Cancer Research — Seattle, Washington

Fred Hutch Cancer Research is a clinical research site located in Seattle, Washington, United States 98109.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Fred Hutch Cancer Research has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Chronic Myelogenous Leukemia - Chronic Phase.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fred Hutch Cancer Research?

Fred Hutch Cancer Research has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fred Hutch Cancer Research conducted?

Fred Hutch Cancer Research has 4 clinical trials on record, with 3 currently active. Their work covers Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Chronic Myelogenous Leukemia - Chronic Phase.

Is Fred Hutch Cancer Research accredited by Crixeo Health?

Fred Hutch Cancer Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fred Hutch Cancer Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.